|
|
N Bhardwaj, A Bender, N Gonzalez, L K Bui, M C Garrett, R M Steinman
J Clin Invest. 1994;
94(2):797
doi:10.1172/JCI117399
Abstract |
Full text
| PDF

A
ntigen-specific, CD8+, cytolytic T lymphocytes (CTLs) could potentially provide resistance to several infectious and malignant diseases. However, the cellular requirements for the generation of specific CTLs in human lymphocyte cultures are not well defined, and repetitive stimulation with antigen is often required. We find that strong CD8+ CTL responses to influenza virus can be generated from freshly isolated blood T cells, as long as dendritic cells are used as antigen presenting cells (APCs). Small numbers of dendritic cells (APC:T cell ratio of 1:50-1:100) induce these CTL responses from most donors in 7 d of culture, but monocytes are weak or inactive. Whereas both dendritic cells and monocytes are infected with influenza virus, the former serve as effective APCs for the induction of CD8+ T cells while the latter act as targets for the CTLs that are induced. The strong CD8+ response to influenza virus-infected dendritic cells is accompanied by extensive proliferation of the CD8+ T cells, but the response can develop in the apparent absence of CD4+ helpers or exogenous lymphokines. CD4+ influenza virus-specific CTLs can also be induced by dendritic cells, but the cultures initially must be depleted of CD8+ cells. These findings should make it possible to use dendritic cells to generate human, antigen-specific, CD8+ CTLs to other targets. The results illustrate the principle that efficient T cell-mediated responses develop in two stages: an afferent limb in which dendritic cells are specialized APCs and an efferent limb in which the primed T cells carry out an immune response to many types of presenting cells.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(89)
| Title and authors |
Publication |
Year |
Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection
William K Decker, Amar Safdar
|
Expert Rev Vaccines
|
2010 |
A new strategy of immune evasion by influenza A virus: Inhibition of monocyte differentiation into dendritic cells
Saikat Boliar, Thomas M. Chambers
|
Veterinary Immunology and Immunopathology
|
2010 |
Regulation of the expression of nitric oxide synthase by Leishmania mexicana amastigotes in murine dendritic cells
Arturo A. Wilkins-Rodríguez, Alma Reyna Escalona-Montaño, Magdalena Aguirre-García, Ingeborg Becker, Laila Gutiérrez-Kobeh
|
Experimental Parasitology
|
2010 |
Dendritic cells in viral bronchiolitis
Paraskevi Maggina, Ioannis Christodoulou, Vassiliki Papaevangelou, Maria Tsolia, Nikolaos G Papadopoulos
|
Expert Rev Clin Immunol
|
2009 |
Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries
Sucharita P. Shankar, Inn Inn Chen, Benjamin G. Keselowsky, Andrés J. García, Julia E. Babensee
|
J. Biomed. Mater. Res.
|
2009 |
Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection.
Michelle A Gill, Kristin Long, Theresa Kwon, Luz Muniz, Asuncion Mejias, John Connolly, Lonnie Roy, Jacques Banchereau, Octavio Ramilo
|
J INFECT DIS
|
2008 |
Dendritic cells: driving the differentiation programme of T cells in viral infections
Frederick Masson, Adele M Mount, Nicholas S Wilson, Gabrielle T Belz
|
Immunol Cell Biol
|
2008 |
New assays to measure equine influenza virus-specific Type 1 immunity in horses
R. Paillot, J.H. Kydd, S. MacRae, J.M. Minke, D. Hannant, J.M. Daly
|
Vaccine
|
2007 |
Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments
Philip Wintermeyer, Jack R. Wands
|
J Gastroenterol
|
2007 |
The threat of avian influenza A (H5N1). Part IV: development of vaccines
Jindrich Cinatl jr, Martin Michaelis, Hans W. Doerr
|
Med Microbiol Immunol
|
2007 |
|